Back

Role of Blood Biomarkers in Cancer Diagnosis and Surveillance

The goal of this program is to improve diagnosis and surveillance of cancer using biomarker analysis. After hearing and assimilating this program, the clinician will be better able to: 1. Describe the potential utility of blood-based biomarkers across the continuum of clinical cancer care. 2. Summarize the potential utility of and challenges associated with use of circulating tumor DNA for cancer surveillance. 3. Evaluate circulating tumor DNA kinetics in response to cancer treatment.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1.25 credits

MOC types

ABIM — Medical KnowledgeUp to 1.25 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Membership pricing — $1,095 / year

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 1.25 credits
  • MOC · Up to 1.25 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Dec 22, 2026 2 months left